FDA expands use of cervical cancer vaccine up to age 45
U.S. regulators have expanded the use of Merck's cervical cancer vaccine to adults up to age 45.
Saturday, October 6, 2018
FDA expands use of cervical cancer vaccine up to age 45
FDA expands use of cervical cancer vaccine up to age 45
U.S. regulators have expanded the use of Merck's cervical cancer vaccine to adults up to age 45.
Related Posts:
0 comments:
Post a Comment